Methyltestosterone

CHEMBL1395 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
302.5 g/mol
LogP
3.4
Phase
4

A synthetic form of testosterone used to treat conditions caused by low testosterone levels in men, and sometimes used in women for certain types of breast cancer. It helps restore normal androgen levels and can slow the growth of hormone-sensitive cancer cells.

Moleküler Ağırlık

302,5000 g/mol

LogP

3,40

TPSA

37,30 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O

InChI

InChI=1S/C20H30O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h12,15-17,22H,4-11H2,1-3H3/t15-,16+,17+,18+,19+,20+/m1/s1

Molecular Formula

C20H30O2

HBD / HBA

1 / 2

Döndürülebilir Bağlar

0

Ağır Atomlar

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A synthetic form of testosterone used to treat conditions caused by low testosterone levels in men, and sometimes used in women for certain types of breast cancer. It helps restore normal androgen levels and can slow the growth of hormone-sensitive cancer cells.

Yes, Methyltestosterone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1395. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6010. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.